Ocaliva - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245108

Publication Date:

October 29, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Obeticholic acid is a听semi-synthetic听bile acid听analogue which has the chemical structure听6伪-ethyl-chenodeoxycholic acid.
The global market for Ocaliva was estimated to be worth US$ 309 million in 2023 and is forecast to a readjusted size of US$ 240.4 million by 2030 with a CAGR of -2.4% during the forecast period 2024-2030
The Ocaliva market is primarily driven by the urgent need for effective treatments for primary biliary cholangitis (PBC), a chronic liver disease that affects the bile ducts. Ocaliva, also known as obeticholic acid, is a medication used to manage PBC and improve liver function. The increasing prevalence of PBC, coupled with advancements in hepatology research and the focus on liver health, contributes to market growth. Moreover, the demonstrated benefits of Ocaliva in reducing serum alkaline phosphatase levels and delaying disease progression further propel adoption. However, challenges include managing potential side effects, optimizing dosing for individual patients, and addressing potential drug interactions. Navigating patient-specific treatment needs, ensuring long-term safety, and providing comprehensive monitoring are ongoing concerns. The market's success relies on continuous research in liver diseases, collaborations between pharmaceutical manufacturers and hepatologists, and comprehensive patient education on the benefits and potential risks of Ocaliva treatment while addressing the evolving challenges associated with liver disease management and treatment accessibility.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ocaliva, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ocaliva by region & country, by Type, and by Application.
The Ocaliva market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocaliva.
麻豆原创 Segmentation
By Company
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma
Segment by Type:
5mg
10mg
Segment by Application
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ocaliva manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ocaliva in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ocaliva in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Ocaliva Product Introduction
1.2 Global Ocaliva 麻豆原创 Size Forecast
1.2.1 Global Ocaliva Sales Value (2019-2030)
1.2.2 Global Ocaliva Sales Volume (2019-2030)
1.2.3 Global Ocaliva Sales Price (2019-2030)
1.3 Ocaliva 麻豆原创 Trends & Drivers
1.3.1 Ocaliva Industry Trends
1.3.2 Ocaliva 麻豆原创 Drivers & Opportunity
1.3.3 Ocaliva 麻豆原创 Challenges
1.3.4 Ocaliva 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ocaliva Players Revenue Ranking (2023)
2.2 Global Ocaliva Revenue by Company (2019-2024)
2.3 Global Ocaliva Players Sales Volume Ranking (2023)
2.4 Global Ocaliva Sales Volume by Company Players (2019-2024)
2.5 Global Ocaliva Average Price by Company (2019-2024)
2.6 Key Manufacturers Ocaliva Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ocaliva Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ocaliva
2.9 Ocaliva 麻豆原创 Competitive Analysis
2.9.1 Ocaliva 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ocaliva Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocaliva as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 5mg
3.1.2 10mg
3.2 Global Ocaliva Sales Value by Type
3.2.1 Global Ocaliva Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ocaliva Sales Value, by Type (2019-2030)
3.2.3 Global Ocaliva Sales Value, by Type (%) (2019-2030)
3.3 Global Ocaliva Sales Volume by Type
3.3.1 Global Ocaliva Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ocaliva Sales Volume, by Type (2019-2030)
3.3.3 Global Ocaliva Sales Volume, by Type (%) (2019-2030)
3.4 Global Ocaliva Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Primary Biliary Cirrhosis
4.1.2 Nonalcoholic Fatty Liver Disease
4.1.3 Other
4.2 Global Ocaliva Sales Value by Application
4.2.1 Global Ocaliva Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ocaliva Sales Value, by Application (2019-2030)
4.2.3 Global Ocaliva Sales Value, by Application (%) (2019-2030)
4.3 Global Ocaliva Sales Volume by Application
4.3.1 Global Ocaliva Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ocaliva Sales Volume, by Application (2019-2030)
4.3.3 Global Ocaliva Sales Volume, by Application (%) (2019-2030)
4.4 Global Ocaliva Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ocaliva Sales Value by Region
5.1.1 Global Ocaliva Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ocaliva Sales Value by Region (2019-2024)
5.1.3 Global Ocaliva Sales Value by Region (2025-2030)
5.1.4 Global Ocaliva Sales Value by Region (%), (2019-2030)
5.2 Global Ocaliva Sales Volume by Region
5.2.1 Global Ocaliva Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ocaliva Sales Volume by Region (2019-2024)
5.2.3 Global Ocaliva Sales Volume by Region (2025-2030)
5.2.4 Global Ocaliva Sales Volume by Region (%), (2019-2030)
5.3 Global Ocaliva Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ocaliva Sales Value, 2019-2030
5.4.2 North America Ocaliva Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ocaliva Sales Value, 2019-2030
5.5.2 Europe Ocaliva Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ocaliva Sales Value, 2019-2030
5.6.2 Asia Pacific Ocaliva Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ocaliva Sales Value, 2019-2030
5.7.2 South America Ocaliva Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ocaliva Sales Value, 2019-2030
5.8.2 Middle East & Africa Ocaliva Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ocaliva Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ocaliva Sales Value
6.2.1 Key Countries/Regions Ocaliva Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ocaliva Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ocaliva Sales Value, 2019-2030
6.3.2 United States Ocaliva Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ocaliva Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ocaliva Sales Value, 2019-2030
6.4.2 Europe Ocaliva Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ocaliva Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ocaliva Sales Value, 2019-2030
6.5.2 China Ocaliva Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ocaliva Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ocaliva Sales Value, 2019-2030
6.6.2 Japan Ocaliva Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ocaliva Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ocaliva Sales Value, 2019-2030
6.7.2 South Korea Ocaliva Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ocaliva Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ocaliva Sales Value, 2019-2030
6.8.2 Southeast Asia Ocaliva Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ocaliva Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ocaliva Sales Value, 2019-2030
6.9.2 India Ocaliva Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ocaliva Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Intercept Pharmaceuticals
7.1.1 Intercept Pharmaceuticals Company Information
7.1.2 Intercept Pharmaceuticals Introduction and Business Overview
7.1.3 Intercept Pharmaceuticals Ocaliva Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Intercept Pharmaceuticals Ocaliva Product Offerings
7.1.5 Intercept Pharmaceuticals Recent Development
7.2 Dainippon Sumitomo Pharma
7.2.1 Dainippon Sumitomo Pharma Company Information
7.2.2 Dainippon Sumitomo Pharma Introduction and Business Overview
7.2.3 Dainippon Sumitomo Pharma Ocaliva Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Dainippon Sumitomo Pharma Ocaliva Product Offerings
7.2.5 Dainippon Sumitomo Pharma Recent Development
8 Industry Chain Analysis
8.1 Ocaliva Industrial Chain
8.2 Ocaliva Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ocaliva Sales Model
8.5.2 Sales Channel
8.5.3 Ocaliva Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Intercept Pharmaceuticals
Dainippon Sumitomo Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.